Lung puncture biopsy and immunohistochemistry diagnosed squamous carcinoma; immunohistochemistry results showed negative PD-L1 expression, and NGS test results were EGFR L858R mutation combined with TP53 mutation, clinical stage IIIB (T4N2M0). This evidence concerns the gene CD274 and squamous cell carcinoma.